- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT03042455
Combined Repetitive Transcranial Magnetic Stimulation and Robot-Assisted Upper Arm Training in Subacute Stroke Patients
Combined Repetitive Transcranial Magnetic Stimulation and Robot-Assisted Upper Arm Training in Subacute Stroke Patients : Randomized Controlled Trial
This study was designed to establish the clinical evidence for effect of Robot-Assisted upper arm training and Repetitive Transcranial Magnetic Stimulation on upper limb function of subacute stroke patients.
- Purpose : to elucidate the effect of Robot-Assisted upper arm training and Repetitive Transcranial Magnetic Stimulation on upper limb function of stroke patients compared to conventional occupational therapy
- Subjects : total 99 patients with stroke whose upper limb functions are impaired
- Intervention : 4 weeks of therapy (5 days per week)
- Studies : upper limb functional assessment (FMA, MFT, WMFT), computerized motion analysis
- Evaluation plan : 1) pre-intervention, 2) post-2 weeks of intervention, 3) post-4 weeks of intervention, 4) 4 weeks after end of intervention
Обзор исследования
Статус
Условия
Вмешательство/лечение
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
-
Seoul, Корея, Республика, 03722
- Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Upper FMA 7-38
- Hemiplegic patients within 6months after stroke onset
- male or female, 20 years older
Exclusion Criteria:
- Patients with cognitive impairment who are unable to comply with protocol-required procedure
- Quadriplegic or double hemiplegic patients
- Patients with musculoskeletal disease, peripheral nerve disease in upper extremity
- Patients with lower motor neuron disease
- Patients who cannot perform rTMS
- Pregnant woman
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
---|---|
Экспериментальный: Robot and rTMS
Robot-Assisted upper arm training and Repetitive Transcranial Magnetic Stimulation group(intervention group 1)
|
The Armeo, a robot with a spring mechanism allowing adjustable arm weight support, can generate assistive forces of up to 66N in flexion/extension and up to 30N for the arm and forearm respectively. This robot integrates seven angle sensors and one pressure sensor that allow direct interaction between the motion of the patient's arm and the associated therapy software. rTMS is a magnetic method used to stimulate small regions of the brain. The Robot and rTMS group will receive the robot-assisted upper arm training and rTMS for 5 times per week, for 4 weeks. And all patients of three groups will receive the additional conventional occupational therapy for 30 minutes daily 5 times per week, for 4 weeks.
Другие имена:
|
Экспериментальный: Robot
Robot-Assisted upper arm training group(intervention group2)
|
The Armeo, a robot with a spring mechanism allowing adjustable arm weight support, can generate assistive forces of up to 66N in flexion/extension and up to 30N for the arm and forearm respectively.
This robot integrates seven angle sensors and one pressure sensor that allow direct interaction between the motion of the patient's arm and the associated therapy software.
The Robot group will receive the robot-assisted upper arm training for 30 minutes daily 5 times per week, for 4 weeks.
And all patients of three groups will receive the additional conventional occupational therapy for 30 minutes daily 5 times per week, for 4 weeks.
Другие имена:
|
Активный компаратор: Conventional
Conventional training group(control group)
|
The conventional group will receive occupational therapy for 30 minutes daily 5 times per week, for 4 weeks instead of Robot or rTMS.
And all patients of three groups will receive the additional conventional occupational therapy for 30 minutes daily 5 times per week, for 4 weeks.
Другие имена:
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
---|---|---|
Fugl-Meyer Assessment (FMA)
Временное ограничение: 1 minute before the first intervention
|
The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index.
It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia.
|
1 minute before the first intervention
|
Fugl-Meyer Assessment (FMA)
Временное ограничение: 2 weeks after the first intervention
|
The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index.
It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia.
|
2 weeks after the first intervention
|
Fugl-Meyer Assessment (FMA)
Временное ограничение: 4 weeks after the first intervention
|
The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index.
It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia.
|
4 weeks after the first intervention
|
Fugl-Meyer Assessment (FMA)
Временное ограничение: 4 weeks after the final intervention
|
The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index.
It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia.
|
4 weeks after the final intervention
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
---|---|---|
Wolf motor function test
Временное ограничение: 1 minute before the first intervention
|
The Wolf Motor Function Test (WMFT) is a quantitative index of upper extremity motor ability examinable through the use of timed and functional tasks.
|
1 minute before the first intervention
|
Wolf motor function test
Временное ограничение: 2 weeks after the first intervention
|
The Wolf Motor Function Test (WMFT) is a quantitative index of upper extremity motor ability examinable through the use of timed and functional tasks.
|
2 weeks after the first intervention
|
Wolf motor function test
Временное ограничение: 4 weeks after the first intervention
|
The Wolf Motor Function Test (WMFT) is a quantitative index of upper extremity motor ability examinable through the use of timed and functional tasks.
|
4 weeks after the first intervention
|
Wolf motor function test
Временное ограничение: 4 weeks after the final intervention
|
The Wolf Motor Function Test (WMFT) is a quantitative index of upper extremity motor ability examinable through the use of timed and functional tasks.
|
4 weeks after the final intervention
|
Manual Function test
Временное ограничение: 1 minute before the first intervention
|
The Manual Function Test (MFT) was developed to evaluate unilateral manual performance in hemiparetic patients after stroke.
|
1 minute before the first intervention
|
Manual Function test
Временное ограничение: 2 weeks after the first intervention
|
The Manual Function Test (MFT) was developed to evaluate unilateral manual performance in hemiparetic patients after stroke.
|
2 weeks after the first intervention
|
Manual Function test
Временное ограничение: 4 weeks after the first intervention
|
The Manual Function Test (MFT) was developed to evaluate unilateral manual performance in hemiparetic patients after stroke.
|
4 weeks after the first intervention
|
Manual Function test
Временное ограничение: 4 weeks after the final intervention
|
The Manual Function Test (MFT) was developed to evaluate unilateral manual performance in hemiparetic patients after stroke.
|
4 weeks after the final intervention
|
Kinematic data of computerized 3D motion analysis
Временное ограничение: 1 minute before the first intervention
|
D motion analysis will be performed using a computerized motion analysis system (VICON MX-T10 System with 6 infrared cameras, Oxford Metrics Inc., Oxford, UK) to measure the kinematic data (angle of each joint) during the task of drinking from a cup
|
1 minute before the first intervention
|
Kinematic data of computerized 3D motion analysis
Временное ограничение: 2 weeks after the first intervention
|
D motion analysis will be performed using a computerized motion analysis system (VICON MX-T10 System with 6 infrared cameras, Oxford Metrics Inc., Oxford, UK) to measure the kinematic data (angle of each joint) during the task of drinking from a cup
|
2 weeks after the first intervention
|
Kinematic data of computerized 3D motion analysis
Временное ограничение: 4 weeks after the first intervention
|
D motion analysis will be performed using a computerized motion analysis system (VICON MX-T10 System with 6 infrared cameras, Oxford Metrics Inc., Oxford, UK) to measure the kinematic data (angle of each joint) during the task of drinking from a cup
|
4 weeks after the first intervention
|
Kinematic data of computerized 3D motion analysis
Временное ограничение: 4 weeks after the final intervention
|
D motion analysis will be performed using a computerized motion analysis system (VICON MX-T10 System with 6 infrared cameras, Oxford Metrics Inc., Oxford, UK) to measure the kinematic data (angle of each joint) during the task of drinking from a cup
|
4 weeks after the final intervention
|
Соавторы и исследователи
Спонсор
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Оценивать)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 1-2014-0083
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .
Клинические исследования Armeo and rTMS
-
University of OsloOslo University Hospital; Vikersund Rehabilitation CenterРекрутингМиотоническая дистрофия 1 типа (DM1)Норвегия
-
Robert Bosch Gesellschaft für Medizinische Forschung...Berufsgenossenschaftliche Unfallklinik Ludwigshafen; Deutsche Gesetzliche Unfallversicherung... и другие соавторыЗавершенный
-
Chang Gung Memorial HospitalРекрутинг
-
The Cleveland ClinicAmerican Heart AssociationЗавершенный
-
The Cleveland ClinicЗавершенныйСердечно-сосудистые заболевания | Сосудистые заболевания | Инсульт | Цереброваскулярные расстройства | Заболевания головного мозга | Заболевания центральной нервной системы | Заболевания нервной системыСоединенные Штаты
-
Centre Hospitalier Universitaire de Saint EtienneЗавершенный
-
University of PittsburghCitrone 33 FoundationЗавершенный
-
Turku University HospitalSatakunta Central HospitalЗавершенный
-
Afyonkarahisar Health Sciences UniversityРекрутингСимптомы нижних мочевыводящих путейТурция
-
Centre Hospitalier du RouvrayUniversity Hospital, Rouen; University Hospital, Caen; Centre Hospitalier Henri LaboritЗавершенныйСильное депрессивное расстройствоФранция